Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Pitavastatin Calcium

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 10,420Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Lupin's Generic Pitavastatin Calcium Receives Approval in the U.S.
    Lupin's Generic Pitavastatin Calcium Receives Approval in the U.S.

    20 Nov 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206029

    FDA
    20 Nov 2023
    Share Share
    Upsher-Smith Launches Pitavastatin Tablets
    Upsher-Smith Launches Pitavastatin Tablets

    06 Nov 2023

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/upsher-smith-launches-pitavastatin-tablets-301977553.html

    PR NEWSWIRE
    06 Nov 2023
    Share Share
    Medicure Announces a Direct to Patient Online Pharmacy Program for of ZYPITAMAG™
    Medicure Announces a Direct to Patient Online Pharmacy Program for of ZYPITAMAG™

    25 Jun 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/medicure-announces-a-direct-to-patient-online-pharmacy-program-for-distribution-of-zypitamag-pitavastatin-tablets-301083656.html

    PRNEWSWIRE
    25 Jun 2020
    Share Share
    Medicure Announces a Direct to Patient Online Pharmacy Program for of ZYPITAMAG™
    Medicure Announces a Direct to Patient Online Pharmacy Program for of ZYPITAMAG™

    25 Jun 2020

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/medicure-announces-a-direct-to-patient-online-pharmacy-program-for-distribution-of-zypitamag-pitavastatin-tablets-301083656.html

    PRNEWSWIRE
    25 Jun 2020
    Share Share
    Medicure Announces Preferred Pricing Agreement for Zypitamag™
    Medicure Announces Preferred Pricing Agreement for Zypitamag™

    04 Oct 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medicure-announces-preferred-pricing-agreement-for-zypitamag-with-the-aids-drug-assistance-program-adap-crisis-task-force-300931003.html

    PR NEWSWIRE
    04 Oct 2019
    Share Share
    Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag™
    Medicure Announces Acquisition Of Full United States Ownership Of Zypitamag™

    01 Oct 2019

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/medicure-announces-acquisition-of-full-united-states-ownership-of-zypitamag-300927426.html

    PR NEWSWIRE
    01 Oct 2019
    Share Share